Read Books Online and Download eBooks, EPub, PDF, Mobi, Kindle, Text Full Free.
Performance Of Pharmaceutical Companies In India
Download Performance Of Pharmaceutical Companies In India full books in PDF, epub, and Kindle. Read online Performance Of Pharmaceutical Companies In India ebook anywhere anytime directly on your device. Fast Download speed and no annoying ads. We cannot guarantee that every ebooks is available!
Book Synopsis Performance of Pharmaceutical Companies in India by : Mainak Mazumdar
Download or read book Performance of Pharmaceutical Companies in India written by Mainak Mazumdar and published by Springer Science & Business Media. This book was released on 2012-10-19 with total page 215 pages. Available in PDF, EPUB and Kindle. Book excerpt: This book explains how government support and institutional set up facilitated the evolution of the Indian pharmaceutical industry and provides an economic analysis of firm strategies due to recent policy changes. The book is useful for researchers interested in understanding the transition of a lifeline sector for an emerging economy like India. Students of public policy, health administrators and health economists who are interested in the functioning of the pharmaceutical sector that produces life saving drugs in developing nations will find this book useful. The book also provides good coverage on data envelopment analysis (DEA), a useful technique for understanding productivity and efficiency. It can provide guidance to the research students on the applicability of DEA technique to address various research questions for analysis. The book will be a valuable addition to libraries in colleges of pharmacy and medicine as well as to all other academic and research centers.
Book Synopsis Relationship between R&D and Financial Performance in Indian Pharmaceutical Industry by : Mithun Nandy
Download or read book Relationship between R&D and Financial Performance in Indian Pharmaceutical Industry written by Mithun Nandy and published by Springer Nature. This book was released on 2021-12-03 with total page 224 pages. Available in PDF, EPUB and Kindle. Book excerpt: The book provides insight into different research and development (R&D) activities performed by Indian pharmaceutical companies. It describes how R&D activities have evolved in the last three decades on Indian soil. The book discusses how emerging economy like India has become the ‘Pharmacy of the World’ and how reputed and research-centric Indian drug manufacturing companies are aligning their business model by incepting the business idea as ‘Innovate in India and Serve to the World’. Subsequently, through successful implementation of the R&D activities and endeavors, Indian pharmaceutical companies have been witnessing different drug discoveries and innovations which have been performed in an indigenous manner. Contemporary marketing strategies adopted by the research-centric Indian pharmaceutical companies for selling innovative drug products across the globe, attaining global competitiveness, and maintaining a seamless supply chain through export initiatives have also been discussed in this book. Finally, the book figures out the relationship between R&D and financial performance with the help of panel data analysis (PDA), an econometric approach.
Book Synopsis Innovation, Economic Development, and Intellectual Property in India and China by : Kung-Chung Liu
Download or read book Innovation, Economic Development, and Intellectual Property in India and China written by Kung-Chung Liu and published by Springer Nature. This book was released on 2019-09-06 with total page 513 pages. Available in PDF, EPUB and Kindle. Book excerpt: This open access book analyses intellectual property codification and innovation governance in the development of six key industries in India and China. These industries are reflective of the innovation and economic development of the two economies, or of vital importance to them: the IT Industry; the film industry; the pharmaceutical industry; plant varieties and food security; the automobile industry; and peer production and the sharing economy. The analysis extends beyond the domain of IP law, and includes economics and policy analysis. The overarching concern that cuts through all chapters is an inquiry into why certain industries have developed in one country and not in the other, including: the role that state innovation policy and/or IP policy played in such development; the nature of the state innovation policy/IP policy; and whether such policy has been causal, facilitating, crippling, co-relational, or simply irrelevant. The book asks what India and China can learn from each other, and whether there is any possibility of synergy. The book provides a real-life understanding of how IP laws interact with innovation and economic development in the six selected economic sectors in China and India. The reader can also draw lessons from the success or failure of these sectors.
Book Synopsis The Efficiency and Productivity of Indian Pharmaceutical Companies by : Aas Mohammad
Download or read book The Efficiency and Productivity of Indian Pharmaceutical Companies written by Aas Mohammad and published by Cambridge Scholars Publishing. This book was released on 2019-09-24 with total page 224 pages. Available in PDF, EPUB and Kindle. Book excerpt: This book evaluates the performance of the Indian pharmaceutical industry, which plays an important role in economic development. It highlights the role the government has had in facilitating the growth of the industry from non-existence, before the 1970s, to being one of the largest pharmaceutical industries in the world today. The text employs various useful techniques to provide an understanding of productivity and efficiency, such as data envelopment analysis, stochastic frontier analysis, the Malmquist Productivity Index and the Hicks-Moorsteen Productivity Index. The book will be useful to health administrators, students of public policy, and health economists with an interest in the pharmaceutical sector.
Book Synopsis Analysis of Financial Performance of Selected Pharmaceutical Companies of India by : P. Rohitkumar
Download or read book Analysis of Financial Performance of Selected Pharmaceutical Companies of India written by P. Rohitkumar and published by Infotech Publishers. This book was released on 2023-02-04 with total page 0 pages. Available in PDF, EPUB and Kindle. Book excerpt: GLOBAL PHARMACEUTICAL INDUSTRY The global pharmaceutical industry is worth US$ 300 billion a year, a figure projected to grow within three years to US$ 400 billion. The 10 biggest drug firms control more than one-third of this market, many with annual revenue of \ more than US$ 10 billion and profit margins of about 30%. Six are based in the \sUSA and four are based in Europe. North and South America, Europe, and Japan are expected to continue to account for a complete 85% of the global pharmaceutical market well into the 21st century. At present, businesses spend one-third of their sales income on selling their goods - nearly double what they spend on research and growth.
Book Synopsis Enhancing Future Skills and Entrepreneurship by : Kuldip Singh Sangwan
Download or read book Enhancing Future Skills and Entrepreneurship written by Kuldip Singh Sangwan and published by Springer Nature. This book was released on 2020-07-27 with total page 281 pages. Available in PDF, EPUB and Kindle. Book excerpt: This open access book presents the proceedings of the 3rd Indo-German Conference on Sustainability in Engineering held at Birla Institute of Technology and Science, Pilani, India, on September 16–17, 2019. Intended to foster the synergies between research and education, the conference is one of the joint activities of the BITS Pilani and TU Braunschweig conducted under the auspices of Indo-German Center for Sustainable Manufacturing, established in 2009. The book is divided into three sections: engineering, education and entrepreneurship, covering a range of topics, such as renewable energy forecasting, design & simulation, Industry 4.0, and soft & intelligent sensors for energy efficiency. It also includes case studies on lean and green manufacturing, and life cycle analysis of ceramic products, as well as papers on teaching/learning methods based on the use of learning factories to improve students’problem-solving and personal skills. Moreover, the book discusses high-tech ideas to help the large number of unemployed engineering graduates looking for jobs become tech entrepreneurs. Given its broad scope, it will appeal to academics and industry professionals alike.
Book Synopsis History of Indigenous Pharmaceutical Companies in Colonial Calcutta (1855–1947) by : Malika Basu
Download or read book History of Indigenous Pharmaceutical Companies in Colonial Calcutta (1855–1947) written by Malika Basu and published by Routledge. This book was released on 2021-01-29 with total page 272 pages. Available in PDF, EPUB and Kindle. Book excerpt: In the context of life and civilization, the pharmaceutical industry is as old as human existence. Since time immemorial India had its own enriched indigenous tradition of medicine. The development of alchemy and its application for human welfare was also an important step in Indian scientific tradition. The present monograph is an innovative attempt to understand the history of the indigenous pharmaceutical companies in Calcutta during the colonial times. Here pharmaceutical companies have been viewed as an illuminating lens to understand the interconnectedness between Indian traditions of thought and Western science and subsequent development of pharmaceutical industry in colonial India. The entire gamut of discussion centres around the issues of medical education, medical services, public health, pharmaceutical profession and politico-economic contexts of the development of pharmaceutical industry in colonial India. Three indigenous pharmaceuticals namely – Butto Krishna Paul & Co., Bengal Chemical & Pharmaceutical Works Limited, and East India Pharmaceutical Works Limited have been studied. The study not only portrays the politico-economic background to the emergence of the pharmaceutical industry in colonial India but links it to the economic nationalism and the quest for self-sufficiency among Indian nationalists and entrepreneurs. The pharmaceutical industry in India can be symbolic of a cultural response to modern science which was to pave the subsequent trajectory of national scientific endeavours in India. Please note: Taylor & Francis does not sell or distribute the Hardback in India, Pakistan, Nepal, Bhutan, Bangladesh and Sri Lanka.
Book Synopsis Growth Strategies Of Indian Pharma Companies by : B Rajesh Kumars M Satish
Download or read book Growth Strategies Of Indian Pharma Companies written by B Rajesh Kumars M Satish and published by ICFAI Books. This book was released on 2007-09-04 with total page 412 pages. Available in PDF, EPUB and Kindle. Book excerpt: The pharmaceutical industry in India is one of the largest and most advanced among the developing countries. During the last three decades, Indian pharmaceutical industry achieved spectacular progress by any standard. India s pharmaceutical industry has b
Book Synopsis The WTO and India's Pharmaceuticals Industry by : Sudip Chaudhuri
Download or read book The WTO and India's Pharmaceuticals Industry written by Sudip Chaudhuri and published by Oxford University Press, USA. This book was released on 2005 with total page 384 pages. Available in PDF, EPUB and Kindle. Book excerpt: The establishment of the World Trade Organization (WTO) in 1995 brought about significant changes in international economic relations between countries. To comply with the Trade Related Aspects of Intellectual Property Rights (TRIPS) Agreement of the WTO, India introduced product patent protection in pharmaceuticals from January 2005. TRIPS has generated a huge controversy in India and abroad. India has emerged as a major source of low-cost, quality drugs for the entire world and thus plays an important role. While there are a large number of pharmaceutical manufacturers in the world, only a handful of multinationals dominate the industry. By using patent rights, multinational companies prevented developing countries like India from realizing their potential of industrial growth and drug prices were among the highest in the world.
Book Synopsis Making Sense of Intellectual Capital by : Daniel Andriessen
Download or read book Making Sense of Intellectual Capital written by Daniel Andriessen and published by Routledge. This book was released on 2004-02-18 with total page 453 pages. Available in PDF, EPUB and Kindle. Book excerpt: Peter Drucker has introduced us all to the knowledge era, where knowledge is the primary resource and intangibles (intellectual capital resources and assets) are now largely recognized as the most important sources of organizations' competitive advantage. With the recognition of the importance of Intangibles comes the problem of how to properly identify them and assign them a value within the corporation. This is an area of concern in 5 fields: 1) accounting and financial reporting, 2) performance measurement and management, 3) valuation in the finance field, 4) the Human Resources field in terms of management, strategy, and planning, and 5) Intellectual Capital. Over the past eight years, over 25 methods have been proposed for the valuation of intangibles coming out of these 5 fields. In this book, Andriessen evaluates 25 existing methods of intangible valuation according to highly developed criteria. In performing his evaluations, Andriessen synthesizes the state of the art research from these fields based on extensive research. He then presents his own method for valuing intangibles, which he began developing and testing as a Senior Manager at KPMG Knowledge Advisory Services in The Netherlands. He relates six case studies in which this method was tested in actual companies, carefully reviews the results of his tests, and then concludes by offering a new and improved method for valuing intangibles in his Weightless Wealth Toolkit, a complete step-by-step process for identifying, valuing, and managing Intangibles to help managers operate successfully in the Intangible Economy.
Book Synopsis The Politics of the Pharmaceutical Industry and Access to Medicines by : Hans Löfgren
Download or read book The Politics of the Pharmaceutical Industry and Access to Medicines written by Hans Löfgren and published by Taylor & Francis. This book was released on 2017-07-06 with total page 370 pages. Available in PDF, EPUB and Kindle. Book excerpt: Some papers presented at a conference held at Hyderabad in September 2010.
Book Synopsis Multi-Criteria Decision Analysis in Management by : Behl, Abhishek
Download or read book Multi-Criteria Decision Analysis in Management written by Behl, Abhishek and published by IGI Global. This book was released on 2020-02-01 with total page 422 pages. Available in PDF, EPUB and Kindle. Book excerpt: Multi-criteria decision making (MCDM) has been extensively used in diverse disciplines, with a variety of MCDM techniques used to solve complex problems. A primary challenge faced by research scholars is to decode these techniques using detailed step-by-step analysis with case studies and data sets. The scope of such work would help decision makers to understand the process of using MCDM techniques appropriately to solve complex issues without making mistakes. Multi-Criteria Decision Analysis in Management provides innovative insights into the rationale behind using MCDM techniques to solve decision-making problems and provides comprehensive discussions on these techniques from their inception, development, and growth to their advancements and applications. The content within this publication examines hybrid multicriteria models, value theory, and data envelopment. Ideal for researchers, management professionals, students, operations scholars, and academicians, this scholarly work supports and enhances the decision-making process.
Book Synopsis Regulatory Affairs in the Pharmaceutical Industry by : Javed Ali
Download or read book Regulatory Affairs in the Pharmaceutical Industry written by Javed Ali and published by Academic Press. This book was released on 2021-11-14 with total page 287 pages. Available in PDF, EPUB and Kindle. Book excerpt: Regulatory Affairs in the Pharmaceutical Industry is a comprehensive reference that compiles all the information available pertaining to regulatory procedures currently followed by the pharmaceutical industry. Designed to impart advanced knowledge and skills required to learn the various concepts of regulatory affairs, the content covers new drugs, generic drugs and their development, regulatory filings in different countries, different phases of clinical trials, and the submission of regulatory documents like IND (Investigational New Drug), NDA (New Drug Application) and ANDA (Abbreviated New Drug Application). Chapters cover documentation in the pharmaceutical industry, generic drug development, code of Federal Regulation (CFR), the ANDA regulatory approval process, the process and documentation for US registration of foreign drugs, the regulation of combination products and medical devices, the CTD and ECTD formats, and much more. Updated reference on drug approval processes in key global markets Provides comprehensive coverage of concepts and regulatory affairs Presents a concise compilation of the regulatory requirements of different countries Introduces the fundamentals of manufacturing controls and their regulatory importance
Book Synopsis Performance of Pharmaceutical Companies in India by : Mainak Mazumdar
Download or read book Performance of Pharmaceutical Companies in India written by Mainak Mazumdar and published by Springer Science & Business Media. This book was released on 2012-10-19 with total page 215 pages. Available in PDF, EPUB and Kindle. Book excerpt: This book explains how government support and institutional set up facilitated the evolution of the Indian pharmaceutical industry and provides an economic analysis of firm strategies due to recent policy changes. The book is useful for researchers interested in understanding the transition of a lifeline sector for an emerging economy like India. Students of public policy, health administrators and health economists who are interested in the functioning of the pharmaceutical sector that produces life saving drugs in developing nations will find this book useful. The book also provides good coverage on data envelopment analysis (DEA), a useful technique for understanding productivity and efficiency. It can provide guidance to the research students on the applicability of DEA technique to address various research questions for analysis. The book will be a valuable addition to libraries in colleges of pharmacy and medicine as well as to all other academic and research centers.
Book Synopsis Transnationalization of Indian Pharmaceutical SMEs by : Jaya Prakash Pradhan
Download or read book Transnationalization of Indian Pharmaceutical SMEs written by Jaya Prakash Pradhan and published by Bookwell Publisher. This book was released on 2008 with total page 164 pages. Available in PDF, EPUB and Kindle. Book excerpt: Indian pharmaceutical small and medium enterprises (SMEs) were traditionally less transnationalized as compared to their large counterparts. National market was their primary focus and their cost-based competitive strategies were sufficient in providing them a sustainable growth within the protective domestic environment created by strong policy interventions. With large scale liberalization measures since 1990s these SMEs are now required to face a globalized competition and are force to transnationalize their business operations to survive. Given the significance of pharmaceutical SMEs in terms of production units, drug production, workers and health security, the issue of transnationalization of these SMEs is of paramount policy relevance. This book critically analyzes the ways in which Indian pharmaceutical SMEs can integrate themselves into the global markets with special focus on the entry strategy of exporting and outward foreign direct investment (OFDI). The transnationalization behaviours of pharmaceutical SMEs has been analyzed from the perspectives of firm-specific factors such as technologies, scale, learning, skills, etc and the overall policy environment. Apart from undertaking pioneering attempt in estimating the size of SME sector in Indian pharmaceutical industry and adopting improved methodology to the analysis of SMEs’ export behaviour, this book has contributed significantly in the understanding of Indian pharmaceutical SMEs’ export behaviour through case study approach. It has successfully brought out various lessons that Indian pharmaceutical SMEs are required to be aware when transnationalizing their businesses. In general pharmaceutical SMEs seem to have a great potential for transnationalization through exports and outward FDI but constrained due to limited financial, technological capabilities and inadequate policy support. After critically evaluating the existing policy framework for the pharmaceutical SMEs, the book advocates urgent need for provision of sufficient low cost finance, strengthening access to national research laboratories, discriminatory incentive rates for SMEs vis-à-vis large firms, promoting pharmaceutical SME cluster and continuous training programmes in transnationalization.
Author :National Academies of Sciences, Engineering, and Medicine Publisher :National Academies Press ISBN 13 :0309468086 Total Pages :235 pages Book Rating :4.3/5 (94 download)
Book Synopsis Making Medicines Affordable by : National Academies of Sciences, Engineering, and Medicine
Download or read book Making Medicines Affordable written by National Academies of Sciences, Engineering, and Medicine and published by National Academies Press. This book was released on 2018-03-01 with total page 235 pages. Available in PDF, EPUB and Kindle. Book excerpt: Thanks to remarkable advances in modern health care attributable to science, engineering, and medicine, it is now possible to cure or manage illnesses that were long deemed untreatable. At the same time, however, the United States is facing the vexing challenge of a seemingly uncontrolled rise in the cost of health care. Total medical expenditures are rapidly approaching 20 percent of the gross domestic product and are crowding out other priorities of national importance. The use of increasingly expensive prescription drugs is a significant part of this problem, making the cost of biopharmaceuticals a serious national concern with broad political implications. Especially with the highly visible and very large price increases for prescription drugs that have occurred in recent years, finding a way to make prescription medicinesâ€"and health care at largeâ€"more affordable for everyone has become a socioeconomic imperative. Affordability is a complex function of factors, including not just the prices of the drugs themselves, but also the details of an individual's insurance coverage and the number of medical conditions that an individual or family confronts. Therefore, any solution to the affordability issue will require considering all of these factors together. The current high and increasing costs of prescription drugsâ€"coupled with the broader trends in overall health care costsâ€"is unsustainable to society as a whole. Making Medicines Affordable examines patient access to affordable and effective therapies, with emphasis on drug pricing, inflation in the cost of drugs, and insurance design. This report explores structural and policy factors influencing drug pricing, drug access programs, the emerging role of comparative effectiveness assessments in payment policies, changing finances of medical practice with regard to drug costs and reimbursement, and measures to prevent drug shortages and foster continued innovation in drug development. It makes recommendations for policy actions that could address drug price trends, improve patient access to affordable and effective treatments, and encourage innovations that address significant needs in health care.
Book Synopsis The Indian Pharmaceutical Industry by : Yaeko Mitsumori
Download or read book The Indian Pharmaceutical Industry written by Yaeko Mitsumori and published by Springer. This book was released on 2018-06-28 with total page 120 pages. Available in PDF, EPUB and Kindle. Book excerpt: This study analyzes the impact of the revision of the Indian Patent Act (2005) on the Indian pharmaceutical industry, which has been achieving healthy growth over the past 30 to 40 years or more. As of 2005, the Indian pharmaceutical industry was ranked as No. 4 in the world in terms of volume and 15th in terms of value. WTO/TRIPS required India to revise its patent law, however, and to introduce product patents in the pharmaceutical field. Many not only in India but also in the world had argued that the local pharmaceutical industry could deteriorate once a strong patent law (such as a product patent) was introduced. However, the Indian pharmaceutical industry has continued to develop rapidly even after the revision of the patent law in 2005. This present study started with efforts to work out the reason the Indian pharmaceutical industry successfully expanded even after the introduction of product patents. The study found that a unique article (the so-called '3-d‘) inserted in the Patent Act 2005 might have played a role in diminishing or preventing a negative impact from the introduction of a strong patent system, such as a product patents. The study also considers that a change of the business model adopted by the Indian pharmaceutical industry might have contributed to diminishing the effect of the negative impact from the introduction of a strong patent law. This study also covers recent developments in India regarding intellectual property rights and the pharmaceutical industry. One is India’s very first compulsory license granted to an Indian pharmaceutical company, Natco, against the large German pharmaceutical firm Bayer; and the second is the Supreme Court decision on Novartis’ Gleevec. The study analyzes the fundamental problems that caused these two events: access to medicine and gaps in the concept of intellectual property in the pharmaceutical industry. As possible solutions to these fundamental issues, this book explores the ideas of voluntary licensing and tiered pricing.
